Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

Conditions:   Methicillin-resistant Staphylococcus Aureus;   Skin Infection Interventions:   Drug: TMP-SMX;   Drug: DOXY Sponsors:   Los Angeles Biomedical Research Institute;   National Institute of Allergy and Infectious Diseases (NIAID);   Washington University School of Medicine;   University of California, Los Angeles Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials